July 13, 2017
Poorer sleep was associated with greater Alzheimer’s disease pathology, as indicated by cerebrospinal fluid biomarkers, according to recent findings.
“Previous evidence has shown that sleep may influence the development or progression of Alzheimer’s disease in various ways,” study researcher Barbara B. Bendlin, PhD, of the University of Wisconsin-Madison, said in a press release. “For example, disrupted sleep or lack of sleep may lead to amyloid plaque buildup because the brain's clearance system kicks into action during sleep. Our study looked not only for amyloid but for other biological markers in the spinal fluid as well.”